BSW
ELV icon

Buckingham Strategic Wealth’s Elevance Health ELV Stock Holding History

Buckingham Strategic Wealth’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$1M Buy
1,854
+243
+15% +$128K 0.01% 332
2024
Q1 		$835K Sell
1,611
-183
-10% -$91K 0.01% 366
2023
Q4 		$846K Sell
1,794
-15
-0.8% -$6.94K 0.01% 353
2023
Q3 		$787K Sell
1,809
-156
-8% -$70.8K 0.01% 328
2023
Q2 		$873K Buy
1,965
+74
+4% +$34.1K 0.01% 313
2023
Q1 		$970K Hold
1,891
– – 0.02% 272
2022
Q4 		$970K Buy
1,891
+320
+20% +$162K 0.02% 273
2022
Q3 		$713K Buy
1,571
+68
+5% +$32.5K 0.01% 299
2022
Q2 		$725K Buy
1,503
+200
+15% +$98.9K 0.01% 300
2022
Q1 		$640K Sell
1,303
-6
-0.5% -$2.74K 0.01% 323
2021
Q4 		$607K Buy
1,309
+202
+18% +$85K 0.01% 335
2021
Q3 		$413K Buy
1,107
+53
+5% +$20.1K 0.01% 397
2021
Q2 		$402K Buy
1,054
+4
+0.4% +$1.53K 0.01% 410
2021
Q1 		$377K Sell
1,050
-33
-3% -$10.6K 0.02% 390
2020
Q4 		$348K Buy
1,083
+83
+8% +$25.5K 0.02% 390
2020
Q3 		$268K Sell
1,000
-138
-12% -$37.1K 0.02% 396
2020
Q2 		$299K Sell
1,138
-67
-6% -$17.9K 0.03% 315
2020
Q1 		$274K Sell
1,205
-40
-3% -$10.9K 0.03% 361
2019
Q4 		$376K Buy
1,245
+139
+13% +$38.3K 0.04% 300
2019
Q3 		$266K Buy
1,106
+3
+0.3% +$822 0.03% 345
2019
Q2 		$311K Sell
1,103
-31
-3% -$8.47K 0.03% 330
2019
Q1 		$325K Sell
1,134
-40
-3% -$11.6K 0.04% 300
2018
Q4 		$308K Buy
1,174
+45
+4% +$12.4K 0.05% 259
2018
Q3 		$309K Buy
1,129
+243
+27% +$63.1K 0.05% 264
2018
Q2 		$211K Buy
+886
New +$205K 0.03% 336
2018
Q1 		– Sell
-1,040
Closed -$234K – 324
2017
Q4 		$234K Sell
1,040
-106
-9% -$22.6K 0.05% 276
2017
Q3 		$218K Buy
+1,146
New +$218K 0.05% 262

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Buckingham Strategic Wealth's ELV Position: Q2 2024 in Review

Buckingham Strategic Wealth increased its Elevance Health (ELV) stake by 15% in Q2 2024, buying an estimated $128K and bringing the position to 1,854 shares worth $1M. The position accounts for 0.01% of the portfolio, ranked #332.

Buckingham Strategic Wealth first reported a position in ELV in Q3 2017 and has held it in 27 quarters since. 1,705 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

  • Buckingham Strategic Wealth held 1,854 shares of Elevance Health worth $1M as of Q2 2024.
  • Buckingham Strategic Wealth bought 243 Elevance Health shares in Q2 2024, an estimated $128K.
  • Elevance Health made up 0.01% of Buckingham Strategic Wealth's portfolio in Q2 2024, its #332 holding.
  • Buckingham Strategic Wealth first reported a position in Elevance Health in Q3 2017 and has held it in 27 quarters since.
  • 1,705 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on Buckingham Strategic Wealth's 13F filing for Q2 2024, filed 12 Aug 2024.